High doses of radiation also in peripheral procedures

Original title: Patient radiation exposure during percutaneous endovascular revascularization of the lower extremity. Reference: Einat Segal et al. Journal of Vascular Surgery. Article in press.

Percutaneous endovascular revascularization is emerging as the first line treatment for peripheral artery disease for both intermittent claudication and chronic critical limb ischemia. Radiation doses for these interventions, usually prolonged, have not been well documented.

This retrospective study evaluated all lower extremity angioplasty procedures between 2006 and 2011 in a single center. Fluoroscopy time and dose area product (DAP) were registered. 382 procedures in 313 patients receiving lower extremity revascularization were included; a significantly higher DAP was observed in the primitive or the external iliac arteries compared to those performed in femoropopliteal (179.6 vs 63.2 Gy/cm2; p

The contraleteral access resulted in a in a higher DAP than the antegrade access (112.2 vs 42.6 Gy/cm2; p < 0.0001). In a multivariable analysis, the anatomical location of lesions presented the strongest association with radiation dose (p

Conclusion:

Revascularization procedures on lower extremities involve substantial radiation doses that can be compared, on average, with abdomen and pelvis CT scans. Pelvis procedures involve higher doses than those performed in femoropopliteal or infrapatellar territories.

 Editorial Comment:

Radiation doses should be taken into account especially in recanalization procedures of iliac arteries. For femoral or intrapatellar procedures, the antegrade access should be preferred whenever possible. Both the technical difficulty of puncture and the greater chance of complications should be counterbalanced with greater support, a stronger drive and now also lower radiation doses.

SOLACI.ORG

More articles by this author

Transcatheter Pulmonary Valve Implantation with a Self-Expanding Valve: Outcomes at 3 Years

Pulmonary regurgitation (PR) is a common condition in patients who have undergone surgical repair of Tetralogy of Fallot or other pathologies involving the right...

RACE Trial: Effect of Balloon Pulmonary Angioplasty and Riociguat on Right Ventricular Afterload and Function in Chronic Thromboembolic Pulmonary Hypertension

Even though pulmonary endarterectomy is the treatment of choice for chronic thromboembolic pulmonary hypertension (CTEPH), up to 40% of patients are not candidates because...

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Percutaneous Tricuspid Valve Replacement with Lux-Valve

Tricuspid regurgitation (TR) is a condition associated with poor quality of life, frequent hospitalizations due to heart failure, and increased mortality, even under optimal...

Transcatheter Pulmonary Valve Implantation with a Self-Expanding Valve: Outcomes at 3 Years

Pulmonary regurgitation (PR) is a common condition in patients who have undergone surgical repair of Tetralogy of Fallot or other pathologies involving the right...

Radial Patency in Coronary Procedures: Is Heparin Enough or Should We Aim for Distal Transradial Access?

Transradial access is the preferred route in most coronary procedures due to its proven reduction in mortality compared to transfemoral access. However, one of...